As a Multi-Country Operator, IMC boasts a Pan-European reach, with operations and distribution network in Germany as well as business partnerships in other Euro-zone countries. In Canada, where the company became the first Israeli-based medical cannabis company to be publicly listed on the Canadian Securities Exchange, IMC is expanding its operational presence in 2021 into the adult-use cannabis space*.
Leveraging long-term extensive experience and insights, IMC has successfully built brand recognition and loyalty among patients and physicians for its premium, consistent, high-quality medical cannabis products.
The company’s unparalleled expertise has enabled it to branch out and expand its business offerings. It provides intellectual property related services and consultancy to the medical cannabis industry born from proprietary processes and technologies developed by IMC for the production of medical cannabis products.
IMC’s European presence is also augmented through strategic alliances with EU-GMP certified suppliers and distributors across the continent. This network provides IMC with the additional breadth, depth and scalability required to expand in Germany and throughout Europe as more jurisdictions move toward cannabis market reforms.
Furthermore, the acquisition of Trichome enhances IMC leadership’s bench strength thanks to the addition of a seasoned Canadian management team with M&A and restructuring expertise to further drive the Company’s growth in one of the world’s top three legal cannabis markets.
IMC plans to bring its premium products to patients and adult-use consumers around the world through continued expansion of its global presence. The company will accomplish this goal through a measured and purposeful acquisition strategy that hinges on:
- The company’s unparalleled experience.
- A proven track record at driving profitability.
- Focusing on attractively valued and highly synergetic acquisition targets.
This formulation will continue to propel IMC as a driving force in the international medical cannabis industry.
*Acquisition of Trichome Financial Corp. was announced on Dec. 30, 2020 and expected to close during H1’21 subject to meeting all regulatory and closing requirements.